Prostatic involution after intraprostatic injection of cobra toxin

Journal of Urology

Volumn 184, Issue 5, 2010, Pages 2192-2196

  Becker, Adam M ^b   Keck, Rick W ^a   Murtagh Jr , Daniel S ^a   Becker, Aaron B ^b   Hinman, Channing ^a   Selman, Steven H ^b  

^a Urology Research Center   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

Botulinum toxin type A; Cobra cardiotoxin proteins; Injections; Prostate; Prostatic hyperplasia

Indexed keywords

BOTULINUM TOXIN A; COBROTOXIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATROPHY; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INVOLUTION; MALE; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; RAT; WEIGHT REDUCTION; ANIMAL; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; INJECTION; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ATROPHY; BOTULINUM TOXIN TYPE A; COBRA CARDIOTOXIN PROTEINS; INJECTIONS; MALE; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; BOTULINUM TOXINS, TYPE A;

EID: 77957851340     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.06.092     Document Type: Article

References (24)

1. C.G. Roehrborn, G. Bartsch, and R. Kirby Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview Urology 58 2001 642
2. P.C. Walsh Treatment of benign prostatic hyperplasia N Engl J Med 335 1996 557
3. H. Lepor The pathophysiology of lower urinary tract symptoms in the aging male population Br J Urol 81 1998 29
4. AUA guideline on management of benign prostatic hyperplasia Chapter 1: diagnosis and treatment recommendations. AUA Practice Guidelines Committee J Urol 170 2003 530
5. M.J. Barry, and C.G. Roehrborn Benign prostatic hyperplasia BMJ 323 2001 1042
6. G.L. Lu-Yao, M.J. Barry, and C.H. Chang Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes Urology 44 1994 692
7. J.D. McConnell, M.J. Barry, and R.C. Bruskewitz Benign prostatic hyperplasia: diagnosis and treatment Agency for Health Care Policy and Research Clin Pract Guidel Quick Ref Guide Clin 1994 pp 1 17
8. G. Brisinda, F. Cadeddu, and S. Vanell Relief by botulinum toxin of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long-term results Urology 73 2009 90
9. C.H. Tsai, S.H. Yang, and C.H. Chien Mechanisms of cardiotoxin III-induced apoptosis in human colorectal cancer COLO205 cells Clin Exp Pharmacol and Physiol 33 2006 177
10. C. Hinman, X.L. Jiang, and H.P. Tang Selective cytolysis by a protein toxin as a consequence of direct interaction with the lymphocyte plasma membrane Toxicol Applied Pharmacol 104 1990 290
11. D.S. Coffey, and P.C. Walsh Clinical and experimental studies of benign prostatic hyperplasia Urol Clin North Am 17 1990 461
12. J.N. Pennefather, W.A. Lau, and F. Mitchelson The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies J Auton Pharmacol 20 2000 193
13. S. Ventura, J. Pennefather, and F. Mitchelson Cholinergic innervation and function in the prostate gland Pharmacol Ther 94 2002 93
14. G. Maria, G. Brisinda, and I.M. Civello Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of randomized, placebo-controlled study Urology 62 2003 259
15. H.C. Kuo Prostate botulinum toxin A injection-an alternative treatment for benign prostatic obstruction in poor surgical candidates Urology 65 2005 670
16. Y.C. Chuang, C.H. Tu, and C.C. Huang Intraprostatic injection of botulinum toxin type A injection relieves bladder outlet obstruction and induces prostate apoptosis BMC Urol 6 2006 12
17. F. Forouhar, W.N. Huang, and J.H. Liu Structural basis of membrane-induced cardiotoxin A3 oligomerization J Biol Chem 278 2003 21980
18. J.B. Harris Myotoxic phospholipases A2 and the regeneration of skeletal muscles Toxicon 42 2003 933 945
19. K.Y. Chien, W.N. Huang, and J.H. Jean Fusion of sphingomyelin vesicles induced by proteins from Taiwan cobra (Naja naja atra) venom Interactions of zwitterionic phospholipids with cardiotoxin analogues J Biol Chem 266 1991 3252
20. C.H. Wang, R. Monette, and S.C. Lee Glycosphingolipid-facilitated membrane insertion and internalization of cobra cardiotoxin Toxicon 46 2005 430
21. S.H. Yang, C.M. Chien, and M.C. Lu Cardiotoxin III induces apoptosis in K562 cells through mitochondria-mediated pathway Clin Exp Pharmacol Physiol 32 2005 515
22. R. Doggweiler, D. Zermann, and M. Ishigooka Botox-induced prostatic involution Prostate 37 1998 44
23. W.J. Jiang, Y.X. Liang, and L.P. Han Purification and characterization of a novel antinociceptive toxin from cobra venom (Naja naja atra) Toxicon 52 2008 638
24. H. Bruschini, R.A. Schmidt, and E.A. Tanagho Neurologic control of prostatic secretion in the dog Invest Urol 15 1978 288